FIELD: medicine.
SUBSTANCE: present invention refers to biotechnology and medicine. There are presented versions (aCt1 and aCt2) of one-domain antibodies specifically binding the Chlamydia trachomatis antigen. There are described versions of the method of inhibiting an infection caused by Chlamydia wherein the method involves the preparation of elementary bodies C.trachomatis by a therapeutically effective amount of the nanoantibody aCt1 or aCt2 before being attached to infected target cells.
EFFECT: use of the invention provides the antibodies to detect and block the infections Chlamydia trachomatis that can find application in medicine.
6 cl, 4 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT PSEUDO-ADENOVIRAL PARTICLE STRAIN EXPRESSING THE CHLAMYDIA TRACHOMATIS CHIMERIC GENE MBL-CT666, A METHOD FOR PREPARING IT, AN IMMUNOGENIC COMPOSITION FOR PROTECTION AGAINST HUMAN UROGENITAL CHLAMYDIOSIS | 2019 |
|
RU2721123C1 |
METHOD FOR MOLECULAR TYPING CHLAMYDIA TRACHOMATIS | 2008 |
|
RU2378364C1 |
IMMUNOGENE COMPOSITION ON BASIS OF ANTIGEN Chlamydia trachomatis (VERSIONS) AND ITS USE | 2004 |
|
RU2352356C2 |
METHOD FOR CHLAMYDIA TRACHOMATIS GENOTYPING | 2010 |
|
RU2443782C1 |
CHLAMYDIAL VACCINE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2676768C2 |
NANOANTIBODIES aMh1, aMh2 BINDING ANTIGEN OF MYCOPLASMA HOMINTS, METHOD OF PRODUCING THEM, METHOD OF TREATING MYCOPLASMA HOMINIS INFECTION | 2011 |
|
RU2484095C1 |
METHOD OF TREATMENT OF COMPLICATED UROGENITAL CLAMIDIOSIS | 2007 |
|
RU2361595C1 |
STRAIN OF HYBRID CULTURED ANIMAL CELLS OF MUS MUSCULUS L USED FOR PRODUCTION OF MONOCLONAL ANTIBODIES TO CHLAMYDIA | 1998 |
|
RU2158760C2 |
APPLICATION OF INDOLE-3-YL GLYOXYLAMIDES FOR SUPPRESSION OF CHLAMYDIA INFECTION | 2012 |
|
RU2493259C1 |
IMMUNISATION AGAINST CHLAMYDIA TRACHOMATIS | 2002 |
|
RU2331435C2 |
Authors
Dates
2013-07-20—Published
2012-01-20—Filed